Open access · OA
via Europe PMC
NAD⁺ biology and supplementation: From mechanisms to clinical perspectives.
Pandolfi S, Ghezzi C, Björklund G, Metalla M, Paone FM, Chirumbolo S.
Molecular biology reports · 2026
Abstract
This study examines the biological and clinical relevance of NAD⁺ supplementation using a combined review and mathematical modelling approach. NAD⁺ plays a central role in cellular energy metabolism, redox balance, and signaling pathways linked to aging, neurodegeneration, and metabolic health. Current evidence shows that oral NAD⁺ precursors such as nicotinamide riboside and nicotinamide mononucleotide can increase circulating NAD⁺ levels, although their clinical benefits remain variable and context-dependent. Intravenous NAD⁺ administration is less well characterized and lacks robust clinical validation. The modelling framework presented here highlights that NAD⁺ responses are nonlinear and influenced by factors such as dose, age, metabolic state, and route of administration. Rather than following a simple dose-response relationship, NAD⁺ supplementation appears to operate within a complex regulatory system involving feedback mechanisms and biological saturation. Overall, these findings emphasize the need for cautious interpretation of current data and for well-designed clinical studies to define effective and safe therapeutic strategies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1007/s11033-026-12351-3
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
S, P., C, G., G, B., M, M., FM, P., & S., C. (2026). NAD⁺ biology and supplementation: From mechanisms to clinical perspectives. <em>Molecular biology reports</em>. https://doi.org/10.1007/s11033-026-12351-3
Vancouver
S P, C G, G B, M M, FM P, S. C. NAD⁺ biology and supplementation: From mechanisms to clinical perspectives. Molecular biology reports. 2026. doi:10.1007/s11033-026-12351-3.
BibTeX
@article{pandolfi2026NADbio,
title = {NAD⁺ biology and supplementation: From mechanisms to clinical perspectives.},
author = {Pandolfi S and Ghezzi C and Björklund G and Metalla M and Paone FM and Chirumbolo S.},
journal = {Molecular biology reports},
year = {2026},
doi = {10.1007/s11033-026-12351-3},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Food Frontiers 2024
Open access · CC-BY
An Updated Review on the Mechanisms, Pre‐Clinical and Clinical Comparisons of Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR)
Current Opinion in Cardiology 2026
Citation only
Role of nicotinamide adenine dinucleotide in cardiovascular disease
Current opinion in cardiology 2026
Citation only
Role of nicotinamide adenine dinucleotide in cardiovascular disease.
Metabolites 2024
Open access · CC-BY
Nicotinamide Mononucleotide Supplementation: Understanding Metabolic Variability and Clinical Implications
IUBMB Life 2023
Open access · OA
Nicotinamide mononucleotide alters body composition and ameliorates metabolic disorders induced by a high‐fat diet
Cell Reports 2020
Open access · CC-BY